Healthcare Marketing for Multi-Specialty Hospitals in India

On 6 October 2026 the National Medical Commission issued its Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners. They took effect on publication, and they invalidate a large part of how hospital marketing is currently sold in India. Patient testimonials are out. Before-and-after imagery is out. Promotional use of a consultant's name, image or voice is out. And lead-generation fees tied to procuring patients are prohibited outright — which means the pricing model most agencies pitch to hospitals is no longer available. Anyone planning healthcare marketing on a cost-per-lead contract is planning something the regulator has just closed.

What remains is narrower, more factual, and considerably more effective than most hospital marketing has ever been.

Truth line: if an agency quotes you a price per patient enquiry, they either have not read the October 2026 guidelines or they are hoping you have not.

What changed on 6 October 2026?

The guidelines were issued by public notice and apply immediately to both registered medical practitioners and institutions.

What is now barred, as reported from the notice:

• Patient testimonials, endorsements, promotional statements, before-and-after depictions and success claims
• Fake, paid or misleading patient reviews, ratings and testimonials
• Buying followers, likes, comments or views, and manipulating search rankings and algorithms
• A doctor permitting their name, image, voice, testimonial or endorsement to be used to promote services or products
• Use of celebrities, influencers, patients, employees or third parties for prohibited testimonials or endorsements
• Paid ranking of doctors on healthcare platforms
• Discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits and free procedures used to encourage unnecessary consultation, tests or treatment
• Commissions, referral fees and lead-generation fees tied to procuring patients
• Fear-based marketing that creates unnecessary demand for procedures or diagnostics

Two provisions deserve to be read twice.

Consent does not cure a testimonial. The guidelines are explicit that consent alone does not make a prohibited use permissible. A hospital that has a signed release from a delighted patient still cannot run that testimonial. Where consent is legally required it must be specific, informed, voluntary, documented and verifiable — and even where disclosure is permitted, providers must avoid identifying patients, including through birthmarks or identification marks.

Using an agency does not transfer the liability. Using an intermediary does not remove a doctor's or institution's responsibility for content they authorised or knowingly permitted. You cannot outsource the exposure. This is the single most important sentence in the guidelines for anyone appointing a marketing partner.

The penalties sit on the doctor, not the hospital

Enforcement runs through the State Medical Councils, with a graduated structure: a warning and mandatory ethics training for a first violation; censure and a monetary penalty for a second; suspension of registration for three to six months for a third; six to twelve months for a serious violation; and removal from the register for one to three years for repeated violations. The council must issue a show-cause notice and a reasoned order, and a practitioner may appeal within sixty days.

Read that against your consultant panel. A campaign your marketing team approves can end with your cardiologist suspended from the register. That asymmetry is why compliance cannot sit with the agency.

What is a hospital still allowed to advertise?

More than most hospital managements believe, and this permission is the foundation of everything that follows.

A hospital or medical institution may publish factual, verifiable information about its name, location, contact details, departments, facilities, equipment, emergency services, accreditation status and charges. What it may not do is use that material for the promotional portrayal of an individual doctor.

Three further permissions matter operationally:

• A hospital website's doctor directory is treated as patient information, not paid advertising. Your consultant listings, qualifications and departmental allocation are legitimate. This is the distinction that saves most hospital websites.
• Hoardings and billboards may carry factual information about infrastructure and facilities. Outdoor is not banned; persuasion in outdoor is.
• Doctors may take part in health awareness and public health campaigns, provided they do not promote their own practice or solicit patients.

There is also a narrow and useful carve-out on superlatives. Comparative claims such as "best" or "No. 1" are permitted only where objectively verifiable through a transparent, independently ascertainable method, and any award or ranking used in advertising must be independently verifiable. That is not a flat ban — it is a substantiation requirement, and almost no hospital in India can currently meet it for the claims it is making.

What is the Factual Floor?

Everything a hospital is expressly permitted to publish is verifiable. Nothing it is permitted to publish is persuasive. That is not a restriction to work around; it is a specification. We build hospital programmes on it and call it the Factual Floor.

Five asset classes sit on that floor, and all five are lawful:

1. Departmental capability pages. One page per clinical department, carrying the equipment actually installed, the procedures actually performed, the sub-specialties covered, consultant qualifications, bed and ICU capacity, and emergency availability. Specific, checkable, and almost entirely absent from Indian hospital websites, which typically run one thin page per department.

2. Accreditation and credential disclosure. Covered in its own section below, because the numbers make it the strongest single asset available.

3. Charges and package transparency. Permitted explicitly. Rare in practice. For a payer-conscious patient comparing two hospitals, a published schedule is a decisive differentiator, and it is one of the few things you can state that a competitor cannot match without matching it.

4. Public health education, consultant-delivered. Doctors may participate in health awareness and public health campaigns. A cardiologist explaining what a stress test measures is education. The same cardiologist explaining why patients should come to his OPD is solicitation. The line is whether the content serves the viewer or the practice, and it is a line you can hold if you write to it deliberately.

5. Emergency and access information. Ambulance numbers, trauma capability, blood bank, hours, routes, insurance desks. Pure logistics, entirely factual, and disproportionately valuable because it reaches people at the moment of highest need.

What you will notice is that none of these require a claim. The Factual Floor works because specificity is more persuasive than persuasion in a category where patients are frightened of being oversold. It is also, not coincidentally, exactly the kind of page structure that search visibility in 2026 rewards.

Why build by department rather than by institution?

Because search intent in healthcare is almost never institutional.

A patient with chest pain does not search for a hospital brand. They search a symptom, then a specialty, then sometimes a named doctor. Each clinical department therefore has its own demand pattern, its own referral pathway, its own payer mix and its own decision timeline — and those timelines differ by more than any other variable in the business. Trauma is instantaneous. Maternity runs months. Elective orthopaedics runs weeks to months of comparison. Oncology is urgent but highly referral-mediated.

One institutional campaign cannot serve those at once. It averages them, and the average fits none. This is the same failure we see in lead generation generally — one undifferentiated funnel standing in for several distinct buying journeys.

Honest caveat on the evidence: there is no published, peer-reviewed Indian data tracking the window from first digital search to admission, segmented by department. Anyone quoting you a precise figure for that is quoting a vendor. The departmental argument rests on the structural observation that these patient journeys are obviously different, not on a benchmark — and the right response is to measure your own by department rather than to adopt someone's average. Our note on measuring marketing ROI sets out how.

Is accreditation actually worth marketing?

This is where the numbers are genuinely surprising, and where the strongest lawful differentiator sits.

As reported in October 2024, NABH full accreditation was held by 1,435 hospitals with 50 or more beds, plus 1,056 facilities under 50 beds. Entry-level HOPE certification was held by roughly 2,659 hospitals over 50 beds and 9,875 smaller facilities.

Against that, there is no official count of hospitals in India, with industry estimates putting facilities over 50 beds at around 45,000 — closer to 100,000 including nursing homes.

So full accreditation among hospitals of your size is held by something in the order of three percent of the market. Accreditation status is explicitly permitted in advertising. Almost nobody who holds it treats it as a marketing asset, and almost everybody who holds it buries it in a footer.

There is a harder commercial number attached. Under IRDAI norms, HOPE-certified hospitals receive a 10% premium over insurance package rates, against 15% for accredited hospitals. NABH's own chief executive has observed that many facilities consider the 10% sufficient — which is precisely why so few progress. That five-point gap makes accreditation a revenue decision before it is a marketing one, and it means the marketing case and the finance case point the same way for once.

NABH has been considering a deadline, reportedly of around two years, to move HOPE-holding hospitals toward full accreditation under its Certification-to-Accreditation programme. If you are sitting on entry-level certification, the window in which full accreditation is a differentiator rather than a baseline is finite.

Has the payer mix changed how patients choose?

Substantially, and it should change your messaging.

Out-of-pocket expenditure has fallen from 64.2% of total health expenditure in 2013-14 to 39.4% in 2021-22, according to the Union Health Ministry's National Health Accounts estimates, announced in September 2024 by NITI Aayog's Member (Health), Dr V K Paul, and the Union Health Secretary. Government health expenditure rose from 1.13% to 1.84% of GDP over the same broad period.

A patient paying 39% of the bill from their own pocket behaves differently from one paying 64%. Empanelment, scheme coverage and insurance desk capability move up the decision hierarchy; headline price moves down. For a mid-sized hospital this means that publishing which schemes and insurers you are empanelled with, and how the cashless process works at your front desk, is now more commercially useful than publishing a discount — which you are no longer permitted to offer as an inducement in any case.

What do the ad platforms allow in India?

Platform policy runs independently of Indian law. An asset can be lawful under the NMC guidelines and still be rejected by an automated filter.

Google. The India section of Google's healthcare and medicines policy names online pharmacies, which require LegitScript Healthcare Merchant Certification plus Google certification and cannot promote prescription drugs in ads or landing pages, and pharmaceutical manufacturers, who may promote over-the-counter medicines with Google certification. It prohibits advertisements for pre-natal gender determination products in India outright — directly relevant if you have radiology and obstetrics departments and anyone is writing ad copy about scans.

Worth being precise here, because vendor content overstates it in both directions: that India section does not address physical providers such as hospitals and clinics at all. It does not impose a certification requirement on them, and it also does not contain a statement declaring them cleared. Anyone telling you a LegitScript certificate is required to run hospital search ads is wrong; anyone citing a Google clearance for hospitals is citing something that is not there.

Meta. The personal attributes policy prohibits ads that assert or imply knowledge of a person's health condition. "Suffering from knee pain? Book your replacement" implies it. "Joint replacement and advanced orthopaedic care available" does not. Rewriting creative from second-person affliction to third-person service availability is the single most common fix needed on hospital social campaigns, and it happens to align exactly with what the NMC now requires anyway.

Google Business Profile. A hospital maintains a primary profile for the facility. Departments with genuinely distinct entrances or hours, and individual practitioners, may hold their own profiles at a shared address — but practitioner listings must reflect real public-facing hours and contact paths, and keyword-stuffed titles invite suspension. Individual consultants running their own clinics alongside hospital hours face a further set of considerations covered in our guide to local SEO for doctors. This is the same discipline covered in our guide to local search visibility, and note that a title like "Dr Sharma — Best Cardiologist Indore" now fails twice: once on Google's naming conventions and once on the NMC's substantiation requirement for superlatives.

Can you market to your own patient database?

This is where hospital marketing teams are most often in breach without knowing it, and the October 2026 guidelines close the gap explicitly by requiring that advertising involving the processing of digital personal data comply with the Digital Personal Data Protection Act, 2023.

The common practice: export patient mobile numbers from the hospital information system, upload them to Meta or Google as a custom audience, and retarget past cardiology patients with a health-checkup offer.

The problem: data collected for the purpose of delivering clinical care has not been consented to for the purpose of marketing. Processing it for a new purpose requires specific, informed consent obtained for that purpose. A clinical consent form is not a marketing consent.

The fix is unglamorous and belongs at the registration desk rather than in the marketing department. Capture a separate, specific, documented marketing consent at the point of patient registration, record it against the patient record, and build your audiences only from the consented set. It will be a smaller list. It will also be a lawful one, and it is the only version that survives a question from your own compliance officer.

What about AI-generated creative?

The guidelines address this directly, which makes India one of the few jurisdictions where medical advertising rules name AI explicitly. For an agency that runs AI production, this is the part worth reading closely.

Per the notice as reported, AI-generated promotional campaigns intended to further commercial interests are prohibited. Conforming promotional content must be labelled as AI-generated or AI-assisted. AI-generated or AI-assisted content cannot carry misleading, deceptive or unverifiable representations. AI cannot be used to create or manipulate a patient's image, testimonial, voice or clinical outcome to produce a synthetic endorsement. Materially AI-altered content must disclose its artificial nature where it could otherwise mislead. Using patient information as an AI input must meet privacy, confidentiality, data-protection and consent requirements. Campaigns for government programmes or schemes serving a larger public interest are exempt.

The practical consequences are concrete. A synthetic patient voiceover is prohibited. An AI-upscaled or AI-altered clinical image used in a campaign requires disclosure. And AI-assisted creative that does conform still carries a labelling obligation that nobody in Indian hospital marketing is currently discharging.

We are an AI-powered agency and we will say plainly what that means here: AI is useful in a hospital programme for drafting departmental content at volume, producing creative variants, and synthesising research — and the output gets labelled where the guidelines require it. AI is not useful for generating patients, faces, outcomes or voices, and in this category that use is now prohibited rather than merely tasteless.

The two older statutes nobody mentions

Two instruments predate all of this and still apply.

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertising treatments or cures for a scheduled list of diseases and conditions. For a hospital this bites hardest on oncology, fertility and certain neurological and metabolic departments: you may advertise that the department exists, what equipment it holds and what procedures it performs, but you may not advertise a cure for a scheduled condition. Breach carries criminal liability, not a regulatory penalty, which puts it in a different category of risk entirely.

The Clinical Establishments (Registration and Regulation) Act, 2010, in states that have adopted it, requires prominent display of the establishment's name, available departments, registered care providers and a complete fee structure. Your advertising should mirror those registrations rather than diverge from them — a department named in a campaign but absent from your registration is a straightforward inconsistency for anyone who checks.

The Consumer Protection Act, 2019 sits over the top, with the Central Consumer Protection Authority empowered to penalise misleading advertisements. Claims of guaranteed cure, 100% success or unsubstantiated market leadership are the standard exposure here, and the authority has shown appetite for the healthcare and wellness category.

Is department-level marketing actually the right lever?

The counter-case is strong and a hospital management should hear it properly rather than be sold past it.

Referral networks probably matter more than anything you advertise. Physician referral, empanelment and insurance tie-ups drive a large share of high-value inpatient volume in India. Building a structured primary-care referral programme may well return more than any patient-facing campaign. I am not going to attach a percentage to that, because the only figures circulating come from studies conducted outside India, and presenting a Nigerian hospital-choice statistic as an Indian fact is the kind of thing that ends a conversation with an informed managing director. The honest position: no national Indian quantification of GP-referral share versus direct digital walk-ins exists in published literature, least of all for tier-2 cities.

Proximity decides acute cases. For trauma, cardiac emergencies and acute presentations — a substantial share of a multi-specialty hospital's revenue — patient destination is determined by geography and ambulance routing. Marketing does not meaningfully enter that decision. Department-level demand generation applies to the elective and planned half of your business, and claiming otherwise is overselling.

Budget spread thin beats nothing, but loses to budget concentrated. Running twelve parallel department programmes on ₹3 lakh a month produces twelve underfunded campaigns, none of which can compete for high-value terms against a corporate chain. The operational answer is to run the Factual Floor across all departments — content and structure cost little per department once the template exists — and to concentrate paid media on two or three departments where you have genuine capability advantage and favourable economics.

And the consultant-branding case has now been settled against it. The original argument for doctor-led personal branding had a real strategic flaw — the audience follows the doctor out of the door when they leave for a corporate chain — and the October 2026 guidelines have made it a compliance problem as well. Build the department's reputation. The department stays.

What this looks like when Midgrow runs it

We would start by auditing what is currently live against the October 2026 guidelines, because for most hospitals that audit produces removals before it produces a plan. Testimonial videos, before-and-after galleries, consultant promotional creative, superlative claims, discount offers and any per-lead agency arrangement all need to come down or be restructured.

Then: departmental capability pages built to the Factual Floor, accreditation and empanelment surfaced rather than buried, charges published where you are willing to compete on transparency, consultant-delivered public health education written to the education-not-solicitation line, a marketing consent captured properly at registration so your database becomes usable, AI-assisted production labelled as the guidelines require, and paid media concentrated on the two or three departments where it pays.

On commercial terms, we will be direct: we work with hospitals on a retainer. We do not price per enquiry or per patient, because commissions, referral fees and lead-generation fees tied to procuring patients are prohibited. If another agency has quoted you a cost per patient, that quote is the problem.

We are based in Indore and we work across performance marketing and content for regulated categories where the constraint is the brief rather than an obstacle to it. If you run a multi-specialty hospital and your current marketing was planned before 6 October 2026, it needs reviewing before it needs scaling.

Talk to us. Book a consultation or message us on WhatsApp at +91 7415603507. Bring your department list, your accreditation status and whatever is currently running. We will tell you what has to come down before we propose anything new.

This article summarises the regulatory position in general terms and is not legal advice. The NMC's notice is available on its own public notices page, and you should take a view on your specific campaigns with your own counsel and compliance team.

Frequently asked questions

Is medical advertising legal in India?

Factual institutional advertising is legal. A hospital may publish verifiable information on its name, location, contact details, departments, facilities, equipment, emergency services, accreditation status and charges. What the October 2026 NMC guidelines prohibit is promotional solicitation, testimonials, outcome claims, fear-based marketing and the promotional portrayal of individual doctors.

Can we use patient testimonial videos?

No. Patient testimonials, endorsements, before-and-after depictions and success claims are prohibited, and the guidelines state explicitly that consent alone does not make a prohibited use permissible. A signed patient release does not create permission.

Can our consultants appear in our marketing?

They can be listed in your website's doctor directory, which the guidelines treat as patient information rather than paid advertising, and they can participate in health awareness and public health education that does not promote their practice or solicit patients. They cannot permit their name, image or voice to be used promotionally. Penalties for breach fall on the doctor's registration, not on the hospital.

Can we pay an agency per patient enquiry?

No. Commissions, referral fees and lead-generation fees tied to procuring patients are prohibited. Retainer or project-based engagement is the compliant structure. Note also that using an intermediary does not remove the hospital's or doctor's responsibility for content they authorised.

Can we advertise discounts on health checkups?

Not as an inducement. Discounts, limited-period offers, contests, coupons, gifts, cashbacks, referral benefits and free procedures cannot be used to encourage unnecessary consultation, tests or treatment. Publishing your actual charges, which the guidelines expressly permit, is the lawful alternative and often the more persuasive one.

Can we say we are the best hospital in the city?

Only if you can substantiate it. Comparative claims such as "best" or "No. 1" are permitted where objectively verifiable through a transparent, independently ascertainable method, and any award or ranking used must be independently verifiable. Most hospitals cannot meet that standard for the claims they are currently making.

Can we retarget our existing patients?

Only with consent obtained for that purpose. The guidelines require advertising involving processing of digital personal data to comply with the Digital Personal Data Protection Act, 2023. Clinical consent is not marketing consent, so uploading patient numbers from your HIS to build a custom audience is a breach unless a specific marketing consent was captured.

Is NABH accreditation worth promoting?

It is the strongest lawful differentiator most hospitals hold. Full accreditation covered 1,435 hospitals of 50-plus beds as of late 2024, against industry estimates of roughly 45,000 such facilities. Accreditation status is expressly permitted in advertising, and under IRDAI norms accredited hospitals receive a 15% premium over insurance package rates against 10% for entry-level certified ones.